Pharmaceutical Firms Consider New Ways to Evaluate Wholesale Distribution Partners

Published: 2005-04-08 06:58:00

Updated: 2005-04-08 06:58:00

The domestic pharmaceutical firms are looking to move away from the existing evaluation method that has influenced the contractual relationships with their wholesale distribution partners, in which the standard industry practice is to establish different set of distribution agreements, including ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK